Yokota et al. reported high expression of GPC1 in 47% of patients with ECC by immunohistochemical staining and that MMAF-conjugated anti-GPC1 antibodies showed potent tumor growth inhibition against GPC1-positive CCA cells in vitro and in vivo [25]. This evidence concerns the gene GPC1 and neoplasm.